These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9109376)

  • 1. Role of Csk in neural differentiation of the embryonic carcinoma cell line P19.
    Takayama Y; Nada S; Nagai K; Okada M
    FEBS Lett; 1997 Apr; 406(1-2):11-6. PubMed ID: 9109376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Src family kinases in the developing rat brain: correlation with their regulator kinase, Csk.
    Inomata M; Takayama Y; Kiyama H; Nada S; Okada M; Nakagawa H
    J Biochem; 1994 Aug; 116(2):386-92. PubMed ID: 7529760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation.
    Sekimoto H; Boney CM
    Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton.
    Thomas SM; Soriano P; Imamoto A
    Nature; 1995 Jul; 376(6537):267-71. PubMed ID: 7617039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSK negatively regulates nerve growth factor induced neural differentiation and augments AKT kinase activity.
    Dey N; Howell BW; De PK; Durden DL
    Exp Cell Res; 2005 Jul; 307(1):1-14. PubMed ID: 15890337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
    Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic activation of c-Src is suppressed by Csk.
    Ohsato Y; Nada S; Okada M; Nakagawa H
    Jpn J Cancer Res; 1994 Oct; 85(10):1023-8. PubMed ID: 7525522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes of gamma-tubulin with nonreceptor protein tyrosine kinases Src and Fyn in differentiating P19 embryonal carcinoma cells.
    Kukharskyy V; Sulimenko V; Macůrek L; Sulimenko T; Dráberová E; Dráber P
    Exp Cell Res; 2004 Aug; 298(1):218-28. PubMed ID: 15242776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma.
    Cam WR; Masaki T; Shiratori Y; Kato N; Ikenoue T; Okamoto M; Igarashi K; Sano T; Omata M
    Cancer; 2001 Jul; 92(1):61-70. PubMed ID: 11443610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice.
    Imamoto A; Soriano P
    Cell; 1993 Jun; 73(6):1117-24. PubMed ID: 7685657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomous maturation of alpha/beta T lineage cells in the absence of COOH-terminal Src kinase (Csk).
    Schmedt C; Tarakhovsky A
    J Exp Med; 2001 Apr; 193(7):815-26. PubMed ID: 11283154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of C-terminal src kinase in human colorectal cancer cell lines.
    Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
    Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of Src family kinases in mouse embryos that lack Csk.
    Nada S; Yagi T; Takeda H; Tokunaga T; Nakagawa H; Ikawa Y; Okada M; Aizawa S
    Cell; 1993 Jun; 73(6):1125-35. PubMed ID: 8513497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of major tyrosine-phosphorylated proteins in Csk-deficient cells.
    Nada S; Okada M; Aizawa S; Nakagawa H
    Oncogene; 1994 Dec; 9(12):3571-8. PubMed ID: 7526315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.
    Kim SO; Avraham S; Jiang S; Zagozdzon R; Fu Y; Avraham HK
    Cancer; 2004 Sep; 101(5):1018-27. PubMed ID: 15329911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syk protein-tyrosine kinase is involved in neuron-like differentiation of embryonal carcinoma P19 cells.
    Tsujimura T; Yanagi S; Inatome R; Takano T; Ishihara I; Mitsui N; Takahashi S; Yamamura H
    FEBS Lett; 2001 Feb; 489(2-3):129-33. PubMed ID: 11165236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pp60src tyrosine kinase modulates P19 embryonal carcinoma cell fate by inhibiting neuronal but not epithelial differentiation.
    Schmidt JW; Brugge JS; Nelson WJ
    J Cell Biol; 1992 Feb; 116(4):1019-33. PubMed ID: 1370835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.